The Exciting Story of Covalent Reversible Inhibition of Rhodesain, a Key Player in African Sleeping Sickness

webinar

Tue, 16 Nov 2021, 15:00 CET (Berlin)

Prof. Dr. Tanja Schirmeister, University of Mainz; Prof. Dr. Bernd Engels, University of Würzburg; Dr. Christian Kersten, University of Mainz; Natalie Fuchs, University of Mainz

The Exciting Story of Covalent Reversible Inhibition of Rhodesain, a Key Player in African Sleeping Sickness

Human African Trypanosomiasis (HAT, African Sleeping Sickness) is a fatal, neglected tropical disease caused by the parasites Trypanosoma brucei. Most available drugs for treatment of the disease lack efficiency and have severe side effects. α-halovinylsulfones as covalent reversible inhibitors of the parasitic cysteine protease “rhodesain” have proven to be promising novel drug candidates.
Here, the team around Tanja focused on optimizing α-fluorovinylsulfones and -sulfonates for rhodesain inhibition using molecular modeling approaches. This resulted in highly potent and selective inhibitors with single-digit nanomolar affinity. The researchers further investigated the binding modes experimentally via MS experiments, indicating that the compounds are covalent-reversible, slow-tight binders. The different inhibition mechanisms of fluorinated and non-fluorinated compounds (reversible vs. irreversible) were investigated by QM/MM calculations and MD simulations.
In vivo studies revealed a favorable metabolism and biodistribution compared to non-optimized rhodesain inhibitors. Furthermore, they observed an anti-trypanosomal activity in the nanomolar range for inhibitors with an N-terminal 2,3-dihydrobenzo[b][1,4]dioxine group and a 4-Me-Phe residue in P2.

 

 

Current news

category
Events
Recap Drugathon 2022
July 13, 2022 13:10 CEST
The first BioSolveIT Drugathon has concluded and the feedback is overwhelming. Over 400 people from around the globe have registered to this unique drug discovery event where research from around the globe collaborate on a single target structure to design novel compounds. The group of Prof. Anna Hirsch volunteered to...
Read on
category
Events
BioSolveIT In-Person Workshop Road Trip Summer 2022
July 12, 2022 16:51 CEST
BioSolveIT celebrates 10 years of our offices in the States with a road trip from the West to the East Coast! Therefore, we will host four in-person workshops in four different cities in the states: San Francisco – July 27th San Diego – July 29th New York City – August...
Read on
category
Software
Introducing Ultra-Fast Pocket Exploration with FastGrow in SeeSAR 12.1
June 24, 2022 11:15 CEST
We are proud to announce the introduction of FastGrow to SeeSAR 12.1 “Narcissus”. Being the world’s fastest app for this, FastGrow enables users to breathtakingly fast search for ligand decorations or extensions that complement unoccupied binding cavities of a target structure. Being developed at Hamburg University in a joint collaboration...
Read on